Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
Titel:
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
Auteur:
MacManus, Michael P. Seymour, John F. Tsang, Hennes Fisher, Richard Keane, Colm Sabdia, Muhammed B. Law, Soi C. Gunawardana, Jay Nath, Karthik Kazakoff, Stephen H. Marques-Piubelli, Mario L. Duenas, Daniela E. Green, Michael R. Roos, Daniel O'Brien, Peter McCann, Andrew Tsang, Richard Davis, Sidney Christie, David Cheah, Chan Amanuel, Benhur Cochrane, Tara Butler, Jason Johnston, Anna Shanavas, Mohamed Li, Li Vajdic, Claire Kridel, Robert Shelton, Victoria Hershenfield, Samantha Baetz, Tara Lebrun, David Johnson, Nathalie Brodtkorb, Marianne Ludvigsen, Maja d’Amore, Francesco Thompson, Ella R. Blombery, Piers Gandhi, Maher K. Tobin, Joshua W.D.